GeneLink, Inc. (GNLKQ) Financial Statements (2024 and earlier)

Company Profile

Business Address 8240 EXCHANGE DRIVE
ORLANDO, FL 32809
State of Incorp. PA
Fiscal Year End December 31
Industry (SIC) 8071 - Medical Laboratories (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments111158
Cash and cash equivalents111158
Receivables21512078
Inventory, net of allowances, customer advances and progress billings293316394
Inventory293316394
Deferred costs929292
Prepaid expense and other current assets1047350
Total current assets:706612772
Noncurrent Assets
Property, plant and equipment220237258
Intangible assets, net (including goodwill)55
Intangible assets, net (excluding goodwill)   55
Deferred costs245268 
Prepaid expense and other noncurrent assets202020
Other undisclosed noncurrent assets8297350
Total noncurrent assets:567623683
TOTAL ASSETS:1,2731,2351,455
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,2151,1551,019
Accounts payable1,2151,1551,019
Deferred revenue and credits232021
Other undisclosed current liabilities875810798
Total current liabilities:2,1141,9851,839
Noncurrent Liabilities
Long-term debt and lease obligation1,1561,1231,090
Long-term debt, excluding current maturities1,1561,1231,090
Liabilities, other than long-term debt388425463
Deferred revenue and credits388425463
Other undisclosed noncurrent liabilities710718725
Total noncurrent liabilities:2,2542,2662,277
Total liabilities:4,3684,2514,116
Equity
Equity, attributable to parent(3,094)(3,015)(2,661)
Common stock2,6272,5772,577
Treasury stock, value(552)(552)(552)
Additional paid in capital23,12222,92622,926
Accumulated deficit(28,291)(27,966)(27,612)
Total equity:(3,094)(3,015)(2,661)
TOTAL LIABILITIES AND EQUITY:1,2731,2351,455

Income Statement (P&L) ($ in thousands)

9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
Revenues
(Revenue, Net)
622400970
Cost of revenue
(Cost of Goods and Services Sold)
(313)(308)(829)
Gross profit:30992141
Operating expenses(549)(450)(2,259)
Operating loss:(240)(357)(2,118)
Nonoperating income (expense)(85)4284
Investment income, nonoperating00670
Interest and debt expense(85)(84)(76)
Loss from continuing operations:(410)(438)(1,910)
Loss before gain (loss) on sale of properties:(410)(438)(1,910)
Net loss:(410)(438)(1,910)
Other undisclosed net income attributable to parent858476
Net loss available to common stockholders, diluted:(325)(354)(1,834)

Comprehensive Income ($ in thousands)

9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
Net loss:(410)(438)(1,910)
Comprehensive loss, net of tax, attributable to parent:(410)(438)(1,910)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: